FDNA

For Evelyn and Miguel, the search for answers felt endless. Like so many families facing a rare disease, they endured years of uncertainty—until FDNA's Face2Gene helped uncover the diagnosis that changed everything. This Rare Disease Day, we recognize the millions still searching for answers. No family should have to navigate this journey alone. Advances in AI-powered phenotyping are bringing hope, accelerating diagnoses, and transforming lives. 💜 Read their story and join us in raising awareness: https://lnkd.in/dUmZzGZ7 #RareDiseaseDay #LightUpForRare #Face2Gene #DiagnosisMatters #AIforRare #FDNA

Every rare disease journey begins with a question and a search for answers. At FDNA, we harness the power of AI to bring those answers closer. Because behind every diagnosis is a life waiting to be understood, a family hoping for clarity. This Rare Disease Day, we stand with the global community—patients, doctors, and advocates—united in one goal: a future where no one is undiagnosed, and every family finds hope. #RareDiseaseDay #LightUpForRare #FDNA

Heading to Los Angeles for ACMG - American College of Medical Genetics and Genomics 2025 meeting? Let’s talk about reducing waiting lists and helping More Qualified Patients access the care they need. Now integrated with the Family Health Assessment, our technology supports pediatricians in identifying patients who may benefit from genetic evaluations. Please schedule a meeting with us at support@fdna.com 🗓️March 19-21, 2025 | Los Angeles, CA #ACMG2025 #Genetics #RareDisease #PrecisionMedicine #FDNA

2025 Stargardt Summit Is Happening Soon! Don’t miss this incredible opportunity to join the #StargardtSummit on Saturday, February 22, 2025! Attend in-person in Newton, MA, or join us virtually from anywhere. Highlights of the day include: ✨ A powerful keynote by Kenyetta McCurdy Byrd ✨ Insightful discussions on research, advocacy, and lived experiences ✨ Exclusive in-person lunch, networking, and breakout sessions Register now at https://lnkd.in/e3AUMBYm and be part of something extraordinary! Special thanks to our sponsor, Alkeus Pharmaceuticals, Inc. and partners, Foundation Fighting Blindness and The Blind Life. #CarrollCenterCommunity #Stargardt #LowVision #SeeWhatsPossible

Why is phenotyping in Africa so critical for the future of genetic research? Dr. AIME LUMAKA shares his insights in this exclusive interview, highlighting the challenges, breakthroughs, and importance of diversity in genetic datasets. #AI #PrecisionMedicine #FDNA

We're thrilled to share how FDNA is pioneering advancements in rare disease diagnosis through cutting-edge AI-powered tools! This time, the spotlight is on Italy, where innovations in genetics and dermatology are making a profound impact, helping clinicians identify rare diseases faster and more accurately, bringing hope to families waiting for answers. In a recent webinar, Giulia Pascolini, MD PhD, Donatella Milani, MD, Giulia Marchetti, MD and Pierluigi Failla, PhD shared their experience and knowledge , highlighting ✅ AI-driven precision for rare syndromes. ✅ Bridging gaps in diagnosis and care. Watch the interesting presentations (in Italian with subtitles in English) #HealthcareInnovation #RareDiseases #AIinMedicine #Genetics #Dermatology #PrecisionMedicine

Exciting news from our partners at the Greenwood Genetic Center (GGC)! Dr. Mike Lyons, Curry Chair in Translational Genomic Therapeutics at GGC, shared insights on SC Business Review about their impactful work and the innovative eConsult offering. At #FDNA, we're proud to collaborate with organizations like GGC that are advancing genomic solutions to improve patient care.

In a groundbreaking study led by Dr. Karen Gripp, FDNA's advanced AI and facial analysis capabilities helped identify a new syndrome linked to prenatal fentanyl exposure. The delineation of this syndrome, which presents distinct facial and physical characteristics, highlights the unique role of AI in advancing early diagnosis for rare conditions. By recognizing subtle facial patterns associated with this disease, FDNA empowers clinicians, parents, and researchers to better understand the impacts of prenatal fentanyl exposure, ultimately contributing to improved medical care and interventions. #AIHealthcare #Genomics #RareDisease #PrecisionMedicine #Face2Gene

Join us next Friday at 10:00 AM CET for the webinar "Fenotipizzazione, disturbi genetici in dermatologia e strumenti di intelligenza artificiale per accelerare la diagnosi di malattie rare in Italia," hosted by #FDNA. This informative session, conducted in Italian, will cover topics such as phenotyping, genetic disorders in dermatology, and the use of artificial intelligence tools to accelerate the diagnosis of rare diseases in Italy: https://lnkd.in/dC_MumM7

Honored to have hosted Dr. AIME LUMAKA and Dr. Gerrye Mubungu at our booth during #ASHG2024! Their dedication to advancing genetic research and phenotyping in Africa inspires our global mission.